Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Charles W. Locuson"'
Autor:
Charles W. Locuson, David C. Rankin, Kate S. KuKanich, Butch KuKanich, Marissa S Komp, Peter Cho, Alyson H. Fitzgerald
Publikováno v:
American Journal of Veterinary Research. 82:171-180
OBJECTIVE To assess the pharmacokinetics and opioid effects of methadone after administration of multiple doses by means of 2 dosing regimens of methadone-fluconazole-naltrexone. ANIMALS 12 healthy Beagles. PROCEDURES Dogs were randomly allocated (6
Publikováno v:
American Journal of Veterinary Research. 81:656-664
OBJECTIVE To determine the effects of coadministration of naltrexone, a human opioid abuse deterrent, on the pharmacokinetics and pharmacodynamics of a methadone-fluconazole combination administered orally to dogs. ANIMALS 12 healthy Beagles. PROCEDU
Autor:
Kellie D. Nance, Colleen M. Niswender, Christopher J. Langmead, Aaron M. Bender, Hyekyung P. Cho, Karl R. Voigtritter, P. Jeffrey Conn, Carrie K. Jones, Thomas M. Bridges, Sichen Chang, Patrick R. Gentry, Vincent B. Luscombe, Kaelyn S. Lingenfelter, Alice E. Berizzi, Jordan C. O’Neill, Craig W. Lindsley, Arthur Christopoulos, Charles W. Locuson, Patrick M. Sexton, Xiaoyan Zhan
Publikováno v:
ACS Chemical Neuroscience. 9:1572-1581
The pharmacology of the M5 muscarinic acetylcholine receptor (mAChR) is the least understood of the five mAChR subtypes due to a historic lack of selective small molecule tools. To address this shortcoming, we have continued the optimization effort a
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics
Meloxicam is a cyclooxygenase (COX) inhibitor with a higher selectivity for cyclooxygenase‐2 (COX‐2) than for cyclooxygenase‐1 (COX‐1). In the laboratory setting, this nonsteroidal anti‐inflammatory drug (NSAID) is commonly selected for ana
Autor:
Aaron M, Bender, Hyekyung P, Cho, Kellie D, Nance, Kaelyn S, Lingenfelter, Vincent B, Luscombe, Patrick R, Gentry, Karl, Voigtritter, Alice E, Berizzi, Patrick M, Sexton, Christopher J, Langmead, Arthur, Christopoulos, Charles W, Locuson, Thomas M, Bridges, Sichen, Chang, Jordan C, O'Neill, Xiaoyan, Zhan, Colleen M, Niswender, Carrie K, Jones, P Jeffrey, Conn, Craig W, Lindsley
Publikováno v:
ACS chemical neuroscience. 9(7)
[Image: see text] The pharmacology of the M(5) muscarinic acetylcholine receptor (mAChR) is the least understood of the five mAChR subtypes due to a historic lack of selective small molecule tools. To address this shortcoming, we have continued the o
Autor:
Colleen M. Niswender, Hyekyung P. Cho, Jerri M. Rook, Anna L. Blobaum, P. Jeffrey Conn, Pedro M. Garcia-Barrantes, Zixiu Xiang, Craig W. Lindsley, Charles W. Locuson, Frank W. Byers
Publikováno v:
Journal of Medicinal Chemistry. 58:7959-7971
The therapeutic potential of selective mGlu1 activation is vastly unexplored relative to the other group I mGlu receptor, mGlu5; therefore, our lab has focused considerable effort toward developing mGlu1 positive allosteric modulators (PAMs) suitable
Autor:
Thomas M. Bridges, P. Jeffrey Conn, Craig W. Lindsley, Charles W. Locuson, J. Scott Daniels, Frank W. Byers, Anna L. Blobaum
Publikováno v:
Drug Metabolism and Disposition. 43:1718-1726
Once thought to be an artifact of microsomal systems, atypical kinetics with cytochrome P450 (CYP) enzymes have been extensively investigated in vitro and found to be substrate and species dependent. Building upon increasing reports of heterotropic C
Autor:
Michael Bubser, C.K. Jones, Charles W. Locuson, Robert W. Gould, Ditte Dencker, Xiaoyan Zhan, Zixiu Xiang, Michael Grannan, Craig W. Lindsley, P.J. Conn, Jürgen Wess
Publikováno v:
ACS Chemical Neuroscience. 6:1683-1695
The M1 muscarinic acetylcholine receptor (mAChR) subtype has been implicated in the underlying mechanisms of learning and memory and represents an important potential pharmacotherapeutic target for the cognitive impairments observed in neuropsychiatr
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 39:122-130
The dog CYP1A2 enzyme is likely an important contributor to the metabolism of veterinary drugs. Dog CYP1A2 is expressed in liver, plus it is inducible and polymorphic, creating the potential for intersubject differences in pharmacokinetics. Hence, th
Publikováno v:
Xenobiotica. 45:495-502
1. Cattle are an important component of the human food chain. Drugs used either legally or illegally in cattle may therefore enter the food chain and it is thus important to understand pathways of drug metabolism in this species, including sulfation